{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:14:17Z","timestamp":1791825257536,"version":"4.3.4"},"reference-count":184,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Functional gastrointestinal disorders (FGIDs) have been re-named as disorders of gut-brain interactions. These conditions are not only common in clinical practice, but also in the community. In reference to the Rome IV criteria, the most common FGIDs, include functional dyspepsia (FD) and irritable bowel syndrome (IBS). Additionally, there is substantial overlap of these disorders and other specific gastrointestinal motility disorders, such as gastroparesis. These disorders are heterogeneous and are intertwined with several proposed pathophysiological mechanisms, such as altered gut motility, intestinal barrier dysfunction, gut immune dysfunction, visceral hypersensitivity, altered GI secretion, presence and degree of bile acid malabsorption, microbial dysbiosis, and alterations to the gut-brain axis. The treatment options currently available include lifestyle modifications, dietary and gut microbiota manipulation interventions including fecal microbiota transplantation, prokinetics, antispasmodics, laxatives, and centrally and peripherally acting neuromodulators. However, treatment that targets the pathophysiological mechanisms underlying the symptoms are scanty. Pharmacological agents that are developed based on the cellular and molecular mechanisms underlying pathologies of these disorders might provide the best avenue for future pharmaceutical development. The currently available therapies lack long-term effectiveness and safety for their use to treat motility disorders and FGIDs. Furthermore, the fundamental challenges in treating these disorders should be defined; for instance, 1. Cause and effect cannot be disentangled between symptoms and pathophysiological mechanisms due to current therapies that entail the off-label use of medications to treat symptoms. 2. Despite the knowledge that the microbiota in our gut plays an essential part in maintaining gut health, their exact functions in gut homeostasis are still unclear. What constitutes a healthy microbiome and further, the precise definition of gut microbial dysbiosis is lacking. More comprehensive, large-scale, and longitudinal studies utilizing multi-omics data are needed to dissect the exact contribution of gut microbial alterations in disease pathogenesis. Accordingly, we review the current treatment options, clinical insight on pathophysiology, therapeutic modalities, current challenges, and therapeutic clues for the clinical care and management of functional dyspepsia, gastroparesis, irritable bowel syndrome, functional constipation, and functional diarrhea.<\/jats:p>","DOI":"10.3389\/fphar.2022.808195","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T03:23:19Z","timestamp":1643080999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":102,"title":["Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders"],"prefix":"10.3389","volume":"13","author":[{"given":"Rajan","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Zogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday C","family":"Ghoshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungil","family":"Ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.gtc.2014.11.008","article-title":"Prokinetics in Gastroparesis","volume":"44","author":"Acosta","year":"2015","journal-title":"Gastroenterol. Clin. North. Am."},{"key":"B2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41586-020-03118-2","article-title":"Local Immune Response to Food Antigens Drives Meal-Induced Abdominal Pain","volume":"590","author":"Aguilera-Lizarraga","year":"2021","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/gut.2007.138982","article-title":"Increased Capsaicin Receptor TRPV1-Expressing Sensory Fibres in Irritable Bowel Syndrome and Their Correlation with Abdominal Pain","volume":"57","author":"Akbar","year":"2008","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1586\/egh.12.34","article-title":"Acotiamide, a Novel Gastroprokinetic for the Treatment of Patients with Functional Dyspepsia: Postprandial Distress Syndrome","volume":"6","author":"Altan","year":"2012","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"B5","first-page":"39","article-title":"Probiotic Therapy for Irritable Bowel Syndrome","volume":"6","author":"Aragon","year":"2010","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5056\/jnm16173","article-title":"Prevalence of Gastric Motility Disorders in Patients with Functional Dyspepsia","volume":"23","author":"Asano","year":"2017","journal-title":"J. Neurogastroenterol Motil."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial Mutualism in the Human Intestine","volume":"307","author":"B\u00e4ckhed","year":"2005","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/gutjnl-2014-308188","article-title":"Randomised Controlled Trial of Mesalazine in IBS","volume":"65","author":"Barbara","year":"","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.5056\/jnm.2011.17.4.349","article-title":"The Immune System in Irritable Bowel Syndrome","volume":"17","author":"Barbara","year":"2011","journal-title":"J. Neurogastroenterol Motil."},{"key":"B10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","article-title":"Activated Mast Cells in Proximity to Colonic Nerves Correlate with Abdominal Pain in Irritable Bowel Syndrome","volume":"126","author":"Barbara","year":"2004","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.gastro.2006.11.039","article-title":"Mast Cell-dependent Excitation of Visceral-Nociceptive Sensory Neurons in Irritable Bowel Syndrome","volume":"132","author":"Barbara","year":"2007","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1053\/j.gastro.2016.02.028","article-title":"The Intestinal Microenvironment and Functional Gastrointestinal Disorders","volume":"150","author":"Barbara","year":"","journal-title":"Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cell.2017.05.034","article-title":"Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways","volume":"170","author":"Bellono","year":"2017","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/ajg.2011.257","article-title":"The Expression and the Cellular Distribution of the Tight junction Proteins Are Altered in Irritable Bowel Syndrome Patients with Differences According to the Disease Subtype","volume":"106","author":"Bertiaux-Vanda\u00eble","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1111\/nmo.12874","article-title":"Effects of Hemin on Heme Oxygenase-1, Gastric Emptying, and Symptoms in Diabetic Gastroparesis","volume":"28","author":"Bharucha","year":"2016","journal-title":"Neurogastroenterol Motil."},{"key":"B16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.chom.2018.05.004","article-title":"Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion","volume":"23","author":"Bhattarai","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","article-title":"Intestinal Permeability-Aa New Target for Disease Prevention and Therapy","volume":"14","author":"Bischoff","year":"2014","journal-title":"BMC Gastroenterol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.cgh.2019.07.007","article-title":"Relative Efficacy of Tegaserod in a Systematic Review and Network Meta-Analysis of Licensed Therapies for Irritable Bowel Syndrome with Constipation","volume":"18","author":"Black","year":"","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1053\/j.gastro.2018.08.021","article-title":"Efficacy of Secretagogues in Patients with Irritable Bowel Syndrome with Constipation: Systematic Review and Network Meta-Analysis","volume":"155","author":"Black","year":"2018","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(20)32115-2","article-title":"Functional Gastrointestinal Disorders: Advances in Understanding and Management","volume":"396","author":"Black","year":"","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41575-020-0286-8","article-title":"Global burden of Irritable Bowel Syndrome: Trends, Predictions and Risk Factors","volume":"17","author":"Black","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.cgh.2019.09.050","article-title":"Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients with Primary Biliary Cholangitis","volume":"18","author":"Bowlus","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e00295","DOI":"10.1002\/prp2.295","article-title":"Therapeutically Targeting Guanylate Cyclase-C: Computational Modeling of Plecanatide, a Uroguanylin Analog","volume":"5","author":"Brancale","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"B24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/hup.1038","article-title":"Duloxetine in the Treatment of Irritable Bowel Syndrome: an Open-Label Pilot Study","volume":"24","author":"Brennan","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1046\/j.1365-2036.2001.01014.x","article-title":"There Are Some Benefits for Eradicating Helicobacter pylori in Patients with Non-ulcer Dyspepsia","volume":"15","author":"Bruley Des Varannes","year":"2001","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"711500","DOI":"10.3389\/fphar.2021.711500","article-title":"New Developments in Prokinetic Therapy for Gastric Motility Disorders","volume":"12","author":"Camilleri","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-018-0038-z","article-title":"Gastroparesis","volume":"4","author":"Camilleri","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1056\/NEJMoa0800670","article-title":"A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation","volume":"358","author":"Camilleri","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","article-title":"Leaky Gut: Mechanisms, Measurement and Clinical Implications in Humans","volume":"68","author":"Camilleri","year":"2019","journal-title":"Gut"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/apt.15711","article-title":"Overall Safety of Relamorelin in Adults with Diabetic Gastroparesis: Analysis of Phase 2a and 2b Trial Data","volume":"51","author":"Camilleri","year":"","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2982.2012.01921.x","article-title":"Intestinal Barrier Function in Health and Gastrointestinal Disease","volume":"24","author":"Camilleri","year":"2012","journal-title":"Neurogastroenterol Motil."},{"key":"B32","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1053\/j.gastro.2021.04.079","article-title":"New Drugs on the Horizon for Functional and Motility Gastrointestinal Disorders","volume":"161","author":"Camilleri","year":"2021","journal-title":"Gastroenterology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/apt.15967","article-title":"Randomised Clinical Trial: Significant Biochemical and Colonic Transit Effects of the Farnesoid X Receptor Agonist Tropifexor in Patients with Primary Bile Acid Diarrhoea","volume":"52","author":"Camilleri","year":"","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1053\/j.gastro.2021.10.028","article-title":"Gastroparesis","volume":"162","author":"Camilleri","year":"2022","journal-title":"Gastroenterology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nrgastro.2013.11","article-title":"Current Management Strategies and Emerging Treatments for Functional Dyspepsia","volume":"10","author":"Camilleri","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrgastro.2017.54","article-title":"Gut Microbiota - at the Intersection of Everything?","volume":"14","author":"Cani","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B37","first-page":"203","article-title":"The Gut-Brain axis: Interactions between Enteric Microbiota, central and Enteric Nervous Systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.14309\/ajg.0000000000000304","article-title":"Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study","volume":"114","author":"Carbone","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1053\/j.gastro.2020.07.029","article-title":"Efficacy and Safety of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in a Randomized, Placebo-Controlled Trial","volume":"160","author":"Carlin","year":"2021","journal-title":"Gastroenterology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1097\/j.pain.0000000000002314","article-title":"Olorinab (APD371), a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, Reduces Colitis-Induced Acute and Chronic Visceral Hypersensitivity in Rodents","volume":"163","author":"Castro","year":"2021","journal-title":"Pain"},{"key":"B41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4161\/gmic.24196","article-title":"Fecal Excretion of Bifidobacterium Infantis 35624 and Changes in Fecal Microbiota after Eight Weeks of Oral Supplementation with Encapsulated Probiotic","volume":"4","author":"Charbonneau","year":"2013","journal-title":"Gut Microbes"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/apt.16304","article-title":"Randomised Study: Effects of the 5-HT4 Receptor Agonist Felcisetrag vs Placebo on Gut Transit in Patients with Gastroparesis","volume":"53","author":"Chedid","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1080\/13543784.2017.1373088","article-title":"Relamorelin for the Treatment of Gastrointestinal Motility Disorders","volume":"26","author":"Chedid","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/ajg.2011.162","article-title":"A Randomized Placebo-Controlled Phase IIb Trial of A3309, a Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation","volume":"106","author":"Chey","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/ajg.2012.254","article-title":"Linaclotide for Irritable Bowel Syndrome with Constipation: a 26-week, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety","volume":"107","author":"Chey","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"23992409e2391","DOI":"10.1053\/j.gastro.2010.02.014","article-title":"CD206-positive M2 Macrophages that Express Heme Oxygenase-1 Protect against Diabetic Gastroparesis in Mice","volume":"138","author":"Choi","year":"2010","journal-title":"Gastroenterology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jcmgh.2016.01.003","article-title":"Intrinsic Gastrointestinal Macrophages: Their Phenotype and Role in Gastrointestinal Motility","volume":"2","author":"Cipriani","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e13427","DOI":"10.1111\/nmo.13427","article-title":"Systematic Review and Meta-Analysis: Efficacy of Patented Probiotic, VSL#3, in Irritable Bowel Syndrome","volume":"30","author":"Connell","year":"2018","journal-title":"Neurogastroenterol Motil."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","article-title":"A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility","volume":"167","author":"Desai","year":"2016","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1053\/j.gastro.2015.01.042","article-title":"Nerve Fiber Outgrowth Is Increased in the Intestinal Mucosa of Patients with Irritable Bowel Syndrome","volume":"148","author":"Dothel","year":"2015","journal-title":"Gastroenterology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1365-2036.2008.03881.x","article-title":"Clinical Trial: Lubiprostone in Patients with Constipation-Associated Irritable Bowel Syndrome-Rresults of Two Randomized, Placebo-Controlled Studies","volume":"29","author":"Drossman","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"00223","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/j.gastro.2017.11.279","article-title":"Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report","volume":"154","author":"Drossman","year":"2018","journal-title":"Gastroenterology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.3748\/wjg.v22.i12.3486","article-title":"Helicobacter pylori Eradication Therapy for Functional Dyspepsia: Systematic Review and Meta-Analysis","volume":"22","author":"Du","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1572-0241.2000.01721.x","article-title":"Domperidone versus Metoclopramide in the Treatment of Diabetic Gastroparesis","volume":"95","author":"Dumitrascu","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","article-title":"Efficacy of Faecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome in a Randomised, Double-Blind, Placebo-Controlled Study","volume":"69","author":"El-Salhy","year":"2020","journal-title":"Gut"},{"key":"B57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12664-020-01144-6","article-title":"The Role of Diet in the Pathophysiology and Management of Irritable Bowel Syndrome","volume":"40","author":"El-Salhy","year":"2021","journal-title":"Indian J. Gastroenterol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/nrdp.2016.14","article-title":"Irritable Bowel Syndrome","volume":"2","author":"Enck","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B59","doi-asserted-by":"publisher","first-page":"17081","DOI":"10.1038\/nrdp.2017.81","article-title":"Functional Dyspepsia","volume":"3","author":"Enck","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B60","doi-asserted-by":"publisher","first-page":"558","DOI":"10.5056\/jnm16001","article-title":"The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments","volume":"22","author":"Farzaei","year":"2016","journal-title":"J. Neurogastroenterol Motil."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0140-6736(20)30469-4","article-title":"Functional Dyspepsia","volume":"396","author":"Ford","year":"2020","journal-title":"Lancet"},{"key":"B62","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/ajg.2014.187","article-title":"American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation","volume":"109","author":"Ford","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.gastro.2014.07.046","article-title":"Confocal Endomicroscopy Shows Food-Associated Changes in the Intestinal Mucosa of Patients with Irritable Bowel Syndrome","volume":"147","author":"Fritscher-Ravens","year":"2014","journal-title":"Gastroenterology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic Review with Meta-Analysis: Rifaximin Is Effective and Safe for the Treatment of Small Intestine Bacterial Overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5152\/tjg.2021.20514","article-title":"Patients with Specific Gastrointestinal Motility Disorders Are Commonly Diagnosed as Functional GI Disorders in the Early Stage by Community Physicians Due to Lack of Awareness","volume":"32","author":"Ghoshal","year":"2021","journal-title":"Turk J. Gastroenterol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/jgh.15032","article-title":"Marshall and Warren Lecture 2019: A Paradigm Shift in Pathophysiological Basis of Irritable Bowel Syndrome and its Implication on Treatment","volume":"35","author":"Ghoshal","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5056\/jnm.2011.17.3.235","article-title":"Epidemiology of Uninvestigated and Functional Dyspepsia in Asia: Facts and Fiction","volume":"17","author":"Ghoshal","year":"","journal-title":"J. Neurogastroenterol Motil."},{"key":"B68","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/jgh.13465","article-title":"Frequency and Risk Factors of Functional Gastro-Intestinal Disorders in a Rural Indian Population","volume":"32","author":"Ghoshal","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"284","DOI":"10.5056\/jnm14071","article-title":"Pathogenesis of Irritable Bowel Syndrome: Is it Really in the Gene?","volume":"20","author":"Ghoshal","year":"2014","journal-title":"J. Neurogastroenterol Motil."},{"key":"B70","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12664-018-0901-6","article-title":"A Randomized Double-Blind Placebo-Controlled Trial Showing Rifaximin to Improve Constipation by Reducing Methane Production and Accelerating colon Transit: A Pilot Study","volume":"37","author":"Ghoshal","year":"2018","journal-title":"Indian J. Gastroenterol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5056\/jnm.2011.17.2.185","article-title":"Slow Transit Constipation Associated with Excess Methane Production and its Improvement Following Rifaximin Therapy: a Case Report","volume":"17","author":"Ghoshal","year":"","journal-title":"J. Neurogastroenterol Motil."},{"key":"B72","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.3168\/jds.2017-13803","article-title":"Bifidobacterium Bifidum YIT 10347 Fermented Milk Exerts Beneficial Effects on Gastrointestinal Discomfort and Symptoms in Healthy Adults: A Double-Blind, Randomized, Placebo-Controlled Study","volume":"101","author":"Gomi","year":"2018","journal-title":"J. Dairy Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e00349","DOI":"10.14309\/ctg.0000000000000349","article-title":"Gastric Mucosal Immune Profiling and Dysregulation in Idiopathic Gastroparesis","volume":"12","author":"Gottfried-Blackmore","year":"2021","journal-title":"Clin. Transl Gastroenterol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/apt.16591","article-title":"Intestinal Chemosensitivity in Irritable Bowel Syndrome Associates with Small Intestinal TRPV Channel Expression","volume":"54","author":"Grover","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1053\/j.gastro.2011.01.046","article-title":"Cellular Changes in Diabetic and Idiopathic Gastroparesis","volume":"140","author":"Grover","year":"2011","journal-title":"Gastroenterology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1136\/gutjnl-2019-318712","article-title":"Gastroparesis: a Turning point in Understanding and Treatment","volume":"68","author":"Grover","year":"2019","journal-title":"Gut"},{"key":"B77","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12920-018-0379-1","article-title":"Transcriptomic Signatures Reveal Immune Dysregulation in Human Diabetic and Idiopathic Gastroparesis","volume":"11","author":"Grover","year":"2018","journal-title":"BMC Med. Genomics"},{"key":"B78","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5056\/jnm16148","article-title":"Mapping of Brain Activations to Rectal Balloon Distension Stimuli in Male Patients with Irritable Bowel Syndrome Using Functional Magnetic Resonance Imaging","volume":"23","author":"Guleria","year":"2017","journal-title":"J. Neurogastroenterol Motil."},{"key":"B79","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cgh.2017.10.021","article-title":"Effects of Amitriptyline and Escitalopram on Sleep and Mood in Patients with Functional Dyspepsia","volume":"16","author":"Herrick","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/apt.15330","article-title":"Systematic Review with Meta-Analysis: Efficacy of Faecal Microbiota Transplantation for the Treatment of Irritable Bowel Syndrome","volume":"50","author":"Ianiro","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"14407","DOI":"10.3748\/wjg.v20.i39.14407","article-title":"Bloating and Functional Gastro-Intestinal Disorders: where Are We and where Are We Going?","volume":"20","author":"Iovino","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/IJGM.S125051","article-title":"Clinical Utility of Plecanatide in the Treatment of Chronic Idiopathic Constipation","volume":"11","author":"Islam","year":"2018","journal-title":"Int. J. Gen. Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"G505","DOI":"10.1152\/ajpgi.00197.2017","article-title":"Effects of NK1 Receptors on Gastric Motor Functions and Satiation in Healthy Humans: Results from a Controlled Trial with the NK1 Antagonist Aprepitant","volume":"313","author":"Jacob","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e13993","DOI":"10.1111\/nmo.13993","article-title":"Muscularis Macrophages Establish Cell-To-Cell Contacts with telocytes\/PDGFR\u03b1-Positive Cells and Smooth Muscle Cells in the Human and Mouse Gastrointestinal Tract","volume":"33","author":"Ji","year":"2021","journal-title":"Neurogastroenterol Motil."},{"key":"B85","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.apsb.2015.05.006","article-title":"Current Developments in Pharmacological Therapeutics for Chronic Constipation","volume":"5","author":"Jiang","year":"2015","journal-title":"Acta Pharm. Sin B"},{"key":"B86","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1053\/j.gastro.2021.04.040","article-title":"Colonic Motility Is Improved by the Activation of 5-HT2B Receptors on Interstitial Cells of Cajal in Diabetic Mice","volume":"161","author":"Jin","year":"2021","journal-title":"Gastroenterology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1572-0241.2007.01524.x","article-title":"Multicenter, 4-week, Double-Blind, Randomized, Placebo-Controlled Trial of Lubiprostone, a Locally-Acting Type-2 Chloride Channel Activator, in Patients with Chronic Constipation","volume":"103","author":"Johanson","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/s1542-3565(04)00356-8","article-title":"Effect of Tegaserod in Chronic Constipation: a Randomized, Double-Blind, Controlled Trial","volume":"2","author":"Johanson","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/apt.16143","article-title":"Review Article: Elobixibat: a Novel Treatment for Chronic Constipation","volume":"53","author":"Khanna","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B90","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nrgastro.2016.98","article-title":"Understanding the Mechanisms of Faecal Microbiota Transplantation","volume":"13","author":"Khoruts","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5056\/jnm.2013.19.2.233","article-title":"Effect of Helicobacter pylori Eradication on Functional Dyspepsia","volume":"19","author":"Kim","year":"2013","journal-title":"J. Neurogastroenterol Motil."},{"key":"B92","doi-asserted-by":"publisher","first-page":"504","DOI":"10.5056\/jnm17066","article-title":"Is Helicobacter pylori Associated Functional Dyspepsia Correlated with Dysbiosis?","volume":"23","author":"Kim","year":"2017","journal-title":"J. Neurogastroenterol Motil."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1136\/gut.2010.213108","article-title":"The Mast Cell Stabiliser Ketotifen Decreases Visceral Hypersensitivity and Improves Intestinal Symptoms in Patients with Irritable Bowel Syndrome","volume":"59","author":"Klooker","year":"2010","journal-title":"Gut"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e000314","DOI":"10.1136\/bmjgast-2019-000314","article-title":"Probiotic L. Gasseri Strain (LG21) for the Upper Gastrointestinal Tract Acting through Improvement of Indigenous Microbiota","volume":"6","author":"Koga","year":"2019","journal-title":"BMJ Open Gastroenterol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/apt.16344","article-title":"Velusetrag Accelerates Gastric Emptying in Subjects with Gastroparesis: a Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase 2 Study","volume":"53","author":"Kuo","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B96","doi-asserted-by":"publisher","first-page":"248","DOI":"10.5056\/jnm19208","article-title":"Expression of Tight Junction Proteins According to Functional Dyspepsia Subtype and Sex","volume":"26","author":"Lee","year":"2020","journal-title":"J. Neurogastroenterol Motil."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.2147\/DDDT.S125743","article-title":"Mirtazapine for Symptom Control in Refractory Gastroparesis","volume":"11","author":"Malamood","year":"2017","journal-title":"Drug Des. Devel Ther."},{"key":"B98","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1046\/j.1365-2036.2003.01695.x","article-title":"Helicobacter pylori Eradication Is Beneficial in the Treatment of Functional Dyspepsia","volume":"18","author":"Malfertheiner","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B99","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1572-0241.2005.40312.x","article-title":"Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR","volume":"100","author":"Malinen","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e00256","DOI":"10.14309\/crj.0000000000000256","article-title":"Mirtazapine for Refractory Gastroparesis","volume":"6","author":"Marella","year":"2019","journal-title":"ACG Case Rep. J."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s40265-020-01414-9","article-title":"Oliceridine: First Approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.cell.2020.08.007","article-title":"Longitudinal Multi-Omics Reveals Subset-specific Mechanisms Underlying Irritable Bowel Syndrome","volume":"182","author":"Mars","year":"2020","journal-title":"Cell"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1136\/gutjnl-2016-311477","article-title":"miR-16 and miR-125b Are Involved in Barrier Function Dysregulation through the Modulation of Claudin-2 and Cingulin Expression in the Jejunum in IBS with Diarrhoea","volume":"66","author":"Mart\u00ednez","year":"2017","journal-title":"Gut"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e13540","DOI":"10.1111\/nmo.13540","article-title":"Acotiamide Affects Antral Motility, but Has No Effect on Fundic Motility, Gastric Emptying or Symptom Perception in Healthy Participants","volume":"31","author":"Masuy","year":"","journal-title":"Neurogastroenterol Motil."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/apt.15191","article-title":"Review Article: Treatment Options for Functional Dyspepsia","volume":"49","author":"Masuy","year":"","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/apt.12080","article-title":"Review Article: Associations between Immune Activation, Intestinal Permeability and the Irritable Bowel Syndrome","volume":"36","author":"Matricon","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B107","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1136\/gutjnl-2011-301454","article-title":"A Placebo-Controlled Trial of Acotiamide for Meal-Related Symptoms of Functional Dyspepsia","volume":"61","author":"Matsueda","year":"2012","journal-title":"Gut"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1001\/archinternmed.2011.533","article-title":"Helicobacter pylori Eradication in Functional Dyspepsia: HEROES Trial","volume":"171","author":"Mazzoleni","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1136\/gutjnl-2019-318747","article-title":"microRNA Overexpression in Slow Transit Constipation Leads to Reduced NaV1.5 Current and Altered Smooth Muscle Contractility","volume":"69","author":"Mazzone","year":"2020","journal-title":"Gut"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1056\/NEJM199812243392601","article-title":"Symptomatic Benefit from Eradicating Helicobacter pylori Infection in Patients with Nonulcer Dyspepsia","volume":"339","author":"McColl","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1572-0241.1998.00160.x","article-title":"Effect of Amitriptyline on Symptoms, Sleep, and Visceral Perception in Patients with Functional Dyspepsia","volume":"93","author":"Mertz","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/j.1365-2036.2000.00706.x","article-title":"Cure of Helicobacter pylori Infection Does Not Improve Symptoms in Non-ulcer Dyspepsia Patients-A Double-Blind Placebo-Controlled Study","volume":"14","author":"Miwa","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1038\/ajg.2009.427","article-title":"Efficacy of the 5-HT1A Agonist Tandospirone Citrate in Improving Symptoms of Patients with Functional Dyspepsia: a Randomized Controlled Trial","volume":"104","author":"Miwa","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","article-title":"The Efficacy of Proton Pump Inhibitors in Nonulcer Dyspepsia: a Systematic Review and Economic Analysis","volume":"127","author":"Moayyedi","year":"2004","journal-title":"Gastroenterology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/gut.2004.047423","article-title":"Amitriptyline Reduces Rectal Pain Related Activation of the Anterior Cingulate Cortex in Patients with Irritable Bowel Syndrome","volume":"54","author":"Morgan","year":"2005","journal-title":"Gut"},{"key":"B116","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41575-020-00397-y","article-title":"Gastrointestinal Biofilms in Health and Disease","volume":"18","author":"Motta","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.cell.2014.04.050","article-title":"Crosstalk between Muscularis Macrophages and Enteric Neurons Regulates Gastrointestinal Motility","volume":"158","author":"Muller","year":"2014","journal-title":"Cell"},{"key":"B118","first-page":"50","article-title":"Frequency of Seropositivity of Helicobacter pylori in Patients Presenting with Dyspepsia","volume":"25","author":"Naz","year":"2013","journal-title":"J. Ayub Med. Coll. Abbottabad"},{"key":"B119","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41583-020-00381-0","article-title":"Gut Microbial Molecules in Behavioural and Neurodegenerative Conditions","volume":"21","author":"Needham","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1053\/j.gastro.2018.11.005","article-title":"How Effective Are Secretagogues for Irritable Bowel Syndrome with Constipation","volume":"155","author":"Pannemans","year":"2018","journal-title":"Gastroenterology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1053\/j.gastro.2010.10.015","article-title":"Clinical Features of Idiopathic Gastroparesis Vary with Sex, Body Mass, Symptom Onset, Delay in Gastric Emptying, and Gastroparesis Severity","volume":"140","author":"Parkman","year":"2011","journal-title":"Gastroenterology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1053\/j.gastro.2021.01.230","article-title":"Functional Dyspepsia and Gastroparesis in Tertiary Care Are Interchangeable Syndromes with Common Clinical and Pathologic Features","volume":"160","author":"Pasricha","year":"2021","journal-title":"Gastroenterology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/j.1572-0241.1999.00456.x","article-title":"A Double-Blind Multicenter Comparison of Domperidone and Metoclopramide in the Treatment of Diabetic Patients with Symptoms of Gastroparesis","volume":"94","author":"Patterson","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s10620-006-9104-6","article-title":"Neomycin Improves Constipation-Predominant Irritable Bowel Syndrome in a Fashion that Is Dependent on the Presence of Methane Gas: Subanalysis of a Double-Blind Randomized Controlled Study","volume":"51","author":"Pimentel","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1023\/a:1014729125428","article-title":"Evolution of Visceral Sensitivity in Patients with Irritable Bowel Syndrome","volume":"47","author":"Poitras","year":"2002","journal-title":"Dig. Dis. Sci."},{"key":"B127","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12664-020-01037-8","article-title":"The Indian Gut Microbiota-Is it Unique?","volume":"39","author":"Pulipati","year":"2020","journal-title":"Indian J. Gastroenterol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11910-017-0802-6","article-title":"Microbiota-Brain-Gut Axis and Neurodegenerative Diseases","volume":"17","author":"Quigley","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1124\/pr.111.004598","article-title":"Functional Selectivity at the \u03bc-opioid Receptor: Implications for Understanding Opioid Analgesia and Tolerance","volume":"63","author":"Raehal","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.3748\/wjg.15.1548","article-title":"Efficacy of Tricyclic Antidepressants in Irritable Bowel Syndrome: a Meta-Analysis","volume":"15","author":"Rahimi","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"e00334","DOI":"10.14309\/ctg.0000000000000334","article-title":"Functional Dyspepsia, Peptic Ulcer, and Helicobacter pylori Infection in a Rural Community of South Asia: An Endoscopy-Assisted Household Survey","volume":"12","author":"Rahman","year":"2021","journal-title":"Clin. Transl Gastroenterol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2036.2009.04189.x","article-title":"Review Article: Metoclopramide and Tardive Dyskinesia","volume":"31","author":"Rao","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/ajg.2012.255","article-title":"A 12-week, Randomized, Controlled Trial with a 4-week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome with Constipation","volume":"107","author":"Rao","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1096\/fj.14-259598","article-title":"Gut Microbes Promote Colonic Serotonin Production through an Effect of Short-Chain Fatty Acids on Enterochromaffin Cells","volume":"29","author":"Reigstad","year":"2015","journal-title":"FASEB J."},{"key":"B135","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nrgastro.2009.35","article-title":"Principles and Clinical Implications of the Brain-Gut-Enteric Microbiota axis","volume":"6","author":"Rhee","year":"2009","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"535","DOI":"10.20524\/aog.2021.0619","article-title":"Comparative Effectiveness of 5-hydroxytryptamine 3 Receptor Antagonists in Irritable Bowel Syndrome: a Network Meta-Analysis of Randomized Controlled Studies","volume":"34","author":"Rokkas","year":"2021","journal-title":"Ann. Gastroenterol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrgastro.2012.168","article-title":"Regulation of Gastrointestinal Motility-Iinsights from Smooth Muscle Biology","volume":"9","author":"Sanders","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/nm.4185","article-title":"Signals from the Gut Microbiota to Distant Organs in Physiology and Disease","volume":"22","author":"Schroeder","year":"2016","journal-title":"Nat. Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut Microbiota in Health and Disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol. Rev."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.14309\/ajg.0000000000001313","article-title":"Tegaserod for Irritable Bowel Syndrome with Constipation in Women Younger Than 65 Years without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials","volume":"116","author":"Shah","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1053\/j.gastro.2020.09.057","article-title":"The Healthy Microbiome-What Is the Definition of a Healthy Gut Microbiome?","volume":"160","author":"Shanahan","year":"2021","journal-title":"Gastroenterology"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/apt.16369","article-title":"Review Article: Diagnosis, Management and Patient Perspectives of the Spectrum of Constipation Disorders","volume":"53","author":"Sharma","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B143","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cgh.2018.08.054","article-title":"The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders","volume":"17","author":"Shin","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1007\/s10620-015-3607-y","article-title":"Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis","volume":"60","author":"Shukla","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-018-0034-5","article-title":"New Treatments and Therapeutic Targets for IBS and Other Functional Bowel Disorders","volume":"15","author":"Simr\u00e9n","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12664-017-0788-7","article-title":"Genetic Variants of Immune-Related Genes IL17F and IL10 Are Associated with Functional Dyspepsia: A Case-Control Study","volume":"36","author":"Singh","year":"2017","journal-title":"Indian J. Gastroenterol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1053\/j.gastro.2020.12.062","article-title":"miR-10b-5p Rescues Diabetes and Gastrointestinal Dysmotility","volume":"160","author":"Singh","year":"","journal-title":"Gastroenterology"},{"key":"B148","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/MEG.0000000000000511","article-title":"Functional Dyspepsia Is Associated with GN\u03b23 C825T and CCK-AR T\/C Polymorphism","volume":"28","author":"Singh","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12664-021-01159-7","article-title":"Micro-organic Basis of Functional Gastrointestinal (GI) Disorders: Role of microRNAs in GI Pacemaking Cells","volume":"40","author":"Singh","year":"","journal-title":"Indian J. Gastroenterol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/jpm11101021","article-title":"Role of microRNAs in Disorders of Gut-Brain Interactions: Clinical Insights and Therapeutic Alternatives","volume":"11","author":"Singh","year":"","journal-title":"Jpm"},{"key":"B151","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5056\/jnm20149","article-title":"Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders","volume":"27","author":"Singh","year":"","journal-title":"J. Neurogastroenterol Motil."},{"key":"B152","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/papr.12801","article-title":"APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the \u03bc-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty","volume":"19","author":"Singla","year":"2019","journal-title":"Pain Pract."},{"key":"B153","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41575-020-0271-2","article-title":"Enteric Nervous System: Sensory Transduction, Neural Circuits and Gastrointestinal Motility","volume":"17","author":"Spencer","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study","volume":"160","author":"Sperber","year":"","journal-title":"Gastroenterology"},{"key":"B155","doi-asserted-by":"publisher","first-page":"00580","DOI":"10.1016\/j.cgh.2021.05.042","article-title":"Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life","author":"Sperber","year":"","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/MED.0b013e3282f43a73","article-title":"Enteroendocrine Cells: a Site of 'taste' in Gastrointestinal Chemosensing","volume":"15","author":"Sternini","year":"2008","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"B157","doi-asserted-by":"publisher","first-page":"e14513","DOI":"10.1097\/MD.0000000000014513","article-title":"Alterations in Fecal Short-Chain Fatty Acids in Patients with Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis","volume":"98","author":"Sun","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"B158","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrgastro.2013.9","article-title":"Helicobacter pylori Infection in Functional Dyspepsia","volume":"10","author":"Suzuki","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5056\/jnm17018","article-title":"The Application of the Rome IV Criteria to Functional Esophagogastroduodenal Disorders in Asia","volume":"23","author":"Suzuki","year":"2017","journal-title":"J. Neurogastroenterol Motil."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cgh.2012.06.036","article-title":"Efficacy of Buspirone, a Fundus-Relaxing Drug, in Patients with Functional Dyspepsia","volume":"10","author":"Tack","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cgh.2015.09.043","article-title":"Efficacy of Mirtazapine in Patients with Functional Dyspepsia and Weight Loss","volume":"14","author":"Tack","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1056\/NEJMra1501505","article-title":"Functional Dyspepsia","volume":"373","author":"Talley","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B163","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/bmj.318.7187.833","article-title":"Eradication of Helicobacter pylori in Functional Dyspepsia: Randomised Double Blind Placebo Controlled Trial with 12 Months' Follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group","volume":"318","author":"Talley","year":"","journal-title":"BMJ"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJM199910073411502","article-title":"Absence of Benefit of Eradicating Helicobacter pylori in Patients with Nonulcer Dyspepsia","volume":"341","author":"Talley","year":"","journal-title":"N. Engl. J. Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/apt.13945","article-title":"Randomised Clinical Trial: Rifaximin versus Placebo for the Treatment of Functional Dyspepsia","volume":"45","author":"Tan","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B166","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-2036.2008.03918.x","article-title":"Amitriptyline Modifies the Visceral Hypersensitivity Response to Acute Stress in the Irritable Bowel Syndrome","volume":"29","author":"Thoua","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B167","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/nmo.12509","article-title":"Centrally Targeted Pharmacotherapy for Chronic Abdominal Pain","volume":"27","author":"T\u00f6rnblom","year":"2015","journal-title":"Neurogastroenterol Motil."},{"key":"B168","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11894-018-0664-3","article-title":"Psychotropics, Antidepressants, and Visceral Analgesics in Functional Gastrointestinal Disorders","volume":"20","author":"T\u00f6rnblom","year":"2018","journal-title":"Curr. Gastroenterol. Rep."},{"key":"B169","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.gie.2012.11.006","article-title":"Breaks in the wall: Increased Gaps in the Intestinal Epithelium of Irritable Bowel Syndrome Patients Identified by Confocal Laser Endomicroscopy (With Videos)","volume":"77","author":"Turcotte","year":"2013","journal-title":"Gastrointest. Endosc."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1053\/j.gastro.2016.02.027","article-title":"Biopsychosocial Aspects of Functional Gastrointestinal Disorders","author":"Van Oudenhove","year":"2016","journal-title":"Gastroenterology"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1111\/j.1572-0241.2003.07583.x","article-title":"Absence of Symptomatic Benefit of Lansoprazole, Clarithromycin, and Amoxicillin Triple Therapy in Eradication of Helicobacter pylori Positive, Functional (Nonulcer) Dyspepsia","volume":"98","author":"Veldhuyzen van Zanten","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.cgh.2017.06.039","article-title":"Bile Acid Deficiency in a Subgroup of Patients with Irritable Bowel Syndrome with Constipation Based on Biomarkers in Serum and Fecal Samples","volume":"16","author":"Vijayvargiya","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1053\/j.gastro.2018.11.069","article-title":"Current Practice in the Diagnosis of Bile Acid Diarrhea","volume":"156","author":"Vijayvargiya","year":"2019","journal-title":"Gastroenterology"},{"key":"B174","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/apt.12999","article-title":"The Response of Patients with Bile Acid Diarrhoea to the Farnesoid X Receptor Agonist Obeticholic Acid","volume":"41","author":"Walters","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1053\/j.gastro.2020.12.016","article-title":"Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients with Functional Dyspepsia","volume":"160","author":"Wauters","year":"2021","journal-title":"Gastroenterology"},{"key":"B176","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1053\/j.gastro.2021.02.060","article-title":"Serotonin Deficiency Is Associated with Delayed Gastric Emptying","volume":"160","author":"Wei","year":"","journal-title":"Gastroenterology"},{"key":"B177","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/jgh3.12528","article-title":"Gut Microbiota Dysbiosis in Functional Gastrointestinal Disorders: Underpinning the Symptoms and Pathophysiology","volume":"5","author":"Wei","year":"","journal-title":"JGH Open"},{"key":"B178","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.chom.2014.09.001","article-title":"Discovery and Characterization of Gut Microbiota Decarboxylases that Can Produce the Neurotransmitter Tryptamine","volume":"16","author":"Williams","year":"2014","journal-title":"Cell Host Microbe"},{"key":"B179","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1053\/j.gastro.2015.12.034","article-title":"Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients with Irritable Bowel Syndrome","volume":"150","author":"Wouters","year":"","journal-title":"Gastroenterology"},{"key":"B180","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/gutjnl-2015-309151","article-title":"The Role of Mast Cells in Functional GI Disorders","volume":"65","author":"Wouters","year":"","journal-title":"Gut"},{"key":"B181","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.immuni.2017.05.011","article-title":"The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut","volume":"46","author":"Yoo","year":"2017","journal-title":"Immunity"},{"key":"B182","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3892\/etm.2013.1109","article-title":"Evaluation of Helicobacter pylori Eradication and Drug Therapy in Patients with Functional Dyspepsia","volume":"6","author":"Zhao","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"B183","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12664-020-01143-7","article-title":"miR-222 Regulates Cell Growth, Apoptosis, and Autophagy of Interstitial Cells of Cajal Isolated from Slow Transit Constipation Rats by Targeting C-Kit","volume":"40","author":"Zheng","year":"2021","journal-title":"Indian J. Gastroenterol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5056\/jnm18206","article-title":"High Prevalence of Slow Transit Constipation in Patients with Gastroparesis","volume":"25","author":"Zikos","year":"2019","journal-title":"J. Neurogastroenterol Motil."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.808195\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T03:23:28Z","timestamp":1643081008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.808195\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":184,"alternative-id":["10.3389\/fphar.2022.808195"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.808195","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"article-number":"808195"}}